The mission of the Neuro-Oncology Symposium is to educate researchers, clinicians, students, trainees, patients, caregivers, and community members on current and developing therapies for brain and nervous system tumors.

This two day virtual event will feature presentations about Fundamental Brain Tumor Science, Translational Research, and Clinical Trials from leading brain cancer experts. This symposium will be of interest to researchers and students as well as physicians and other health care providers. Please reach out to braintumor@umn.edu with any questions.

Thank You Sponsors!

We would also like to thank the family of Dr. John R. Ohlfest for partnering with the Neuro-Oncology Symposium through the years. Dr. Ohlfest was the director of the Neurosurgery Gene Therapy Program, and associate professor in the Department of Pediatrics, was a recognized pioneer in the treatment of brain tumors using both gene therapy and novel immunotherapies in an attempt to boost a patient’s own immune system to attack the cancer. Dr. Ohlfest passed away in 2013 after a battle with malignant melanoma.

Welcome

On behalf of the Masonic Cancer Center at the University of Minnesota and our Brain Tumor Program, I'd like to welcome you to the 5th biennial Minnesota Neuro-Oncology Symposium. We are very pleased to be sponsoring such a fantastic group of speakers this year from around the country and globe, who are making a difference for understanding brain tumor development and for developing new treatments. This includes Dr. Suzanne J. Baker, Ph.D. of St. Jude's Children's Hospital, who will deliver our Dr. John R. Ohlfest memorial lecture. We're pleased to offer this symposium with our partners in the Departments of Neurosurgery and Pediatrics and our many close collaborators at the Mayo Clinic.